The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Toll-like receptor 9 (TLR9) agonists in the treatment of cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Toll-like receptor control of the adaptive immune responses
Iwasaki, A., & Medzhitov, R. (2004) · Nature Immunology · doi:10.1038/ni1112 · Cited by 4,193
Therapeutic potential of Toll-like receptor 9 activation
Krieg, A. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2059 · Cited by 1,246
Self-citationToll-like receptors stimulate human neutrophil function
Hayashi, F., Means, T. K., & Luster, A. D. (2003) · Blood · doi:10.1182/blood-2003-04-1078 · Cited by 939
Speiser, D. E., Líénard, D., Rufer, N., Rubio‐Godoy, V., Rimoldi, D., Lejeune, F. J., Krieg, A. Μ., Cerottini, J., & Romero, P. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523373 · Cited by 640
Self-citationLee, J., Mo, J.-H., Katakura, K., Alkalay, I., Rucker, A. N., Liu, Y.-T., Lee, H.-K., Shen, C., Cojocaru, G., Shenouda, S., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1500 · Cited by 623
Human Keratinocytes Express Functional Toll-Like Receptor 3, 4, 5, and 9
Lebre, M. C., van der Aar, A. M. G., van Baarsen, L., van Capel, T. M. M., Schuitemaker, J. H. N., Kapsenberg, M. L., & de Jong, E. C. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700530 · Cited by 486
Ligand-induced conformational changes allosterically activate Toll-like receptor 9
Latz, E., Verma, A., Visintin, A., Gong, M., Sirois, C. M., Klein, D. C. G., Monks, B. G., McKnight, C. J., Lamphier, M. S., Duprex, W. P., et al. (2007) · Nature Immunology · doi:10.1038/ni1479 · Cited by 465
Development of TLR9 agonists for cancer therapy
Krieg, A. M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31414 · Cited by 429
Self-citationHuman lung cancer cells express functionally active Toll-like receptor 9
Droemann, D., Albrecht, D., Gerdes, J., Ulmer, A. J., Branscheid, D., Vollmer, E., Dalhoff, K., Zabel, P., & Goldmann, T. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-1 · Cited by 340
IFN-α Regulates TLR-Dependent Gene Expression of IFN-α, IFN-β, IL-28, and IL-29
Sirén, J., Pirhonen, J., Julkunen, I., & Matikainen, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.1932 · Cited by 238
Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma1
Carpentier, A., Laigle-Donadey, F., Zohar, S., Capelle, L., Behin, A., Tibi, A., Martin-Duverneuil, N., Sanson, M., Lacomblez, L., Taillibert, S., et al. (2006) · Neuro-Oncology · doi:10.1215/s1522851705000475 · Cited by 212
Decker, T., Schneller, F., Sparwasser, T., Tretter, T., Lipford, G. B., Wagner, H., & Peschel, C. (2000) · Blood · doi:10.1182/blood.v95.3.999.003k10_999_1006 · Cited by 210
Pashenkov, M., Goëss, G., Wagner, C., Hörmann, M., Jandl, T., Moser, A., Britten, C. M., Smolle, J., Koller, S., Mauch, C., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9129 · Cited by 210
Self-citationFranzius, C., Daldrup-Link, H. E., Wagner-Bohn, A., Sciuk, J., Heindel, W. L., Jürgens, H., & Schober, O. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf012 · Cited by 203
Wooldridge, J. E., Ballas, Z., Krieg, A. M., & Weiner, G. J. (1997) · Blood · doi:10.1182/blood.v89.8.2994 · Cited by 203
Self-citationGelman, A. E., LaRosa, D. F., Zhang, J., Walsh, P. T., Choi, Y., Sunyer, J. O., & Turka, L. A. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.023 · Cited by 202
Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides
Krieg, A. M. (2004) · Current Oncology Reports · doi:10.1007/s11912-004-0019-0 · Cited by 200
Self-citationRingdén, O., Labopin, M., Gorin, N.-C., Le Blanc, K., Rocha, V., Gluckman, E., Reiffers, J., Arcese, W., Vossen, J. M., Jouet, J.-P., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.102 · Cited by 191
Dávila, E., Kennedy, R. B., & Celis, E. (2003) · PubMed · Cited by 182
Manegold, C., Gravenor, D., Woytowitz, D., Mezger, J., Hirsh, V., Albert, G., Al-Adhami, M., Readett, D., Krieg, A. M., & Leichman, C. G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.5807 · Cited by 171
Self-citationFriedberg, J. W., Kim, H., McCauley, M., Hessel, E. M., Sims, P. W., Fisher, D. C., Nadler, L. M., Coffman, R. L., & Freedman, A. S. (2004) · Blood · doi:10.1182/blood-2004-06-2156 · Cited by 154
Link, B. K., Ballas, Z. K., Weisdorf, D. J., Wooldridge, J. E., Bossler, A., Shannon, M., Rasmussen, W. L., Krieg, A. Μ., & Weiner, G. J. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000211304.60126.8f · Cited by 153
Self-citationAppay, V., Jandus, C., Voelter, V., Reynard, S., Coupland, S. E., Rimoldi, D., Líénard, D., Guillaume, P., Krieg, A. Μ., Cerottini, J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1670 · Cited by 152
Self-citationCpG Oligodeoxynucleotide Enhances Tumor Response to Radiation
Milas, L., Mason, K. A., Ariga, H., Hunter, N. R., Neal, R. E., Valdecanas, D. R., Krieg, A. Μ., & Whisnant, J. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0926 · Cited by 151
Self-citationMicrobial DNA Induces a Host Defense Reaction of Human Respiratory Epithelial Cells
Platz, J., Beißwenger, C., Dalpke, A. H., Koczulla, R., Pinkenburg, O., Vogelmeier, C. F., & Bals, R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1219 · Cited by 145
Pedersen, G., Andresen, L. O., Matthiessen, M. W., Rask-Madsen, J., & Brynskov, J. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02848.x · Cited by 138
CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigens
Jahrsdörfer, B., Hartmann, G., Racila, E. V., Jackson, W. J., Mühlenhoff, L., Meinhardt, G., Endres, S., Link, B. K., Krieg, A. Μ., & Weiner, G. J. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.1.81 · Cited by 137
Self-citationWeigel, B. J., Rodeberg, D. A., Krieg, A. Μ., & Blazar, B. R. (2003) · PubMed · Cited by 133
Self-citationMolenkamp, B. G., van Leeuwen, P. A. M., Meijer, S., Sluijter, B. J. R., Wijnands, P. G. J. T. B., Baars, A., van den Eertwegh, A. J. M., Scheper, R. J., & de Gruijl, T. D. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0050 · Cited by 131
Immune-mediated tumor regression induced by CpG-containing oligodeoxynucleotides.
Baines, J., & Celis, E. (2003) · PubMed · Cited by 122
Leonard, J. P., Link, B. K., Emmanouilides, C. E., Gregory, S. A., Weisdorf, D. J., Andrey, J., Hainsworth, J. D., Sparano, J. A., Tsai, D. E., Horning, S. J., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0815 · Cited by 108
Self-citationJahrsdörfer, B., Wooldridge, J. E., Blackwell, S. E., Taylor, C. M., Griffith, T. S., Link, B. K., & Weiner, G. J. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0604373 · Cited by 103
Wysocka, M., Benoit, B. M., Newton, S. B., Azzoni, L., Montaner, L. J., & Rook, A. H. (2004) · Blood · doi:10.1182/blood-2004-03-1190 · Cited by 97
Damiano, V., Caputo, R., Bianco, R., D'Armiento, F. P., Leonardi, A., De Placido, S., Bianco, A. R., Agrawal, S., Ciardiello, F., & Tortora, G. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1943 · Cited by 90
CpG DNA-mediated immune response in pulmonary endothelial cells
Li, J., Ma, Z., Tang, Z.-L., Stevens, T., Pitt, B. R., & Li, S. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00436.2003 · Cited by 83
Prognosis of Premenopausal Breast Cancer and Childbirth Prior to Diagnosis
Phillips, K., Milne, R. L., Friedlander, M. L., Jenkins, M. A., McCredie, M. R. E., Giles, G. G., & Hopper, J. L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.062 · Cited by 79
Damiano, V., Caputo, R., Garofalo, S., Bianco, R., Rosa, R., Merola, G., Gelardi, T., Racioppi, L., Fontanini, G., De Placido, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705226104 · Cited by 71
Saikh, K. U., Kissner, T. L., Sultana, A., Ruthel, G. T., & Ulrich, R. G. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7426 · Cited by 71
CpG DNA and cancer immunotherapy: orchestrating the antitumor immune response
Wooldridge, J. E., & Weiner, G. J. (2003) · Current Opinion in Oncology · doi:10.1097/00001622-200311000-00006 · Cited by 50
Daftarian, P. M., Song, G.-Y., Ali, S., Faynsod, M., Longmate, J., Diamond, D. J., & Ellenhorn, J. D. I. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0169 · Cited by 46
Thompson, J. A., Kuzel, T. M., Bukowski, R., Masciari, F., & Schmalbach, T. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.14_suppl.4644 · Cited by 24
Leichman, G., Gravenor, D. S., Woytowitz, D., Mezger, J., Albert, G. R., Schmalbach, T., Al-Adhami, M., & Manegold, C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.7039 · Cited by 20
Readett, D., Denis, L., Krieg, A. Μ., et al. (2007) · Journal of Thoracic Oncology · doi:10.1097/01.jto.0000283400.75592.3b · Cited by 6
Self-citation
Cited by
Keefe, A. D., Pai, S., & Ellington, A. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3141 · Cited by 2,289
Targeting Toll-like receptors: emerging therapeutics?
Hennessy, E. J., Parker, A. E., & O'Neill, L. A. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3203 · Cited by 886
Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
Bates, P. J., Laber, D. A., Miller, D. M., Thomas, S. D., & Trent, J. O. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2009.01.004 · Cited by 874
Aptamers and Their Biological Applications
Song, K.-M., Lee, S., & Ban, C. (2012) · Sensors · doi:10.3390/s120100612 · Cited by 821
JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression
Owen, K. L., Brockwell, N. K., & Parker, B. S. (2019) · Cancers · doi:10.3390/cancers11122002 · Cited by 714
Metadata
- Authors
- Krieg, A. M.
- Venue
- Oncogene
- Published
- 2008-01-07
- Volume
- 27
- Issue
- 2
- Pages
- 161-167
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2039461003
- Cited by
- 388
- References
- 44
- FWCI
- 12.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.